###begin article-title 0
###xml 88 96 88 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
A role for the Tec family kinase ITK in regulating SEB induced Interleukin-2 production in vivo via c-jun phosphorylation
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 112 133 112 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Staphyloccocus aureus</italic>
###xml 209 211 206 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 535 544 532 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 621 628 618 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 685 689 <span type="species:ncbi:10090">mice</span>
Exposure to Staphylococcal Enterotoxin B (SEB), a bacterial superantigen secreted by the Gram-positive bacteria Staphyloccocus aureus, results in the expansion and eventual clonal deletion and anergy of Vbeta8+ T cells, as well as massive cytokine release, including Interleukin-2 (IL-2). This IL-2 is rapidly secreted following exposure to SEB and may contribute to the symptoms seen following exposure to this bacterial toxin. The Tec family kinase ITK has been shown to be important for the production of IL-2 by T cells stimulated in vitro and may represent a good target for blocking the production of this cytokine in vivo. In order to determine if ITK represents such a target, mice lacking ITK were analyzed for their response to SEB exposure.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 120 128 120 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 141 148 141 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 250 258 250 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 283 290 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 292 300 292 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 475 477 472 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 505 506 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 547 549 538 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
It was found that T cells from mice lacking ITK exhibited significantly reduced proliferative responses to SEB exposure in vitro, as well as in vivo. Examination of IL-2 production revealed that ITK null mice produced reduced levels of this cytokine in vitro, and more dramatically, in vivo. In vivo analysis of c-jun phosphorylation, previously shown to be critical for regulating IL-2 production, revealed that this pathway was specifically activated in SEB reactive Vbeta8+ (but not non-reactive Vbeta6+) T cells from WT mice, but not in Vbeta8+ T cells from ITK null mice. However, toxicity analysis indicated that both WT and ITK null animals were similarly affected by SEB exposure.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
These data show that ITK is required for IL-2 production induced by SEB in vivo, and may regulate signals leading IL-2 production, in part by regulating phosphorylation of c-jun. The data also suggest that perturbing T cell activation pathways leading to IL-2 does not necessarily lead to improved responses to SEB toxicity.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 199 200 199 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 431 432 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 433 434 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 877 878 868 869 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 941 942 921 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 943 944 923 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1105 1106 1085 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1107 1108 1087 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 718 722 <span type="species:ncbi:10090">mice</span>
Superantigens (SAGs) are microbial toxins of bacterial and viral origin with the ability to activate 5-20% of the T cell population, causing T cell activation, cytokine release and systemic shock [1,2]. Most SAGs share the ability to simultaneously bind the class II major histocompatibility complex molecules and the variable region of the T cell receptor beta-chain, without the need to be processed by antigen presenting cells [1,2]. Thus SEB can interact directly with MHC class II molecules on APCs and activate T cells bearing the proper TcR Vbeta chains. The result of this interaction is large-scale stimulation of any T cell that expresses the proper TCR Vbeta chain. A number of studies have shown that when mice are challenged with a SAG such as Staphylococcal Enterotoxin B (SEB), toxicity results from massive induction of cytokines derived from T-helper-type-1 (TH1) type cells such as IL-2, IFN-gamma, TNF-alpha and TNF-beta [1,3]. This cytokine production is accompanied by expansion of the numbers of SEB reactive T cells, followed by cell death and the induction of functional "anergy" [4-6].
###end p 9
###begin p 10
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro</italic>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 544 546 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
In order for a T cell to be activated antigen presenting cells (APC) must present antigen, either an antigenic peptide or SAG. In vitro, this interaction with the TcR has been shown to lead to the activation of a number of tyrosine kinases, including the Src family kinase Lck, the Syk family kinase Zap-70 and the Tec family kinase ITK (for review see [7-10]). This then results in the activation of a number of signaling pathways including members of the MAPK family of kinases, ERK, JNK and p38, followed by transcription factor activation [10]. In vivo, activation of these T cells lead to the induction of cytokine secretion within hours of SEB exposure [1,3].
###end p 10
###begin p 11
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 135 144 135 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 220 228 220 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 265 274 265 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 278 285 278 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 293 294 293 294 <sub xmlns:xlink="http://www.w3.org/1999/xlink">H</sub>
###xml 342 344 342 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 405 414 405 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 814 823 814 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 827 834 827 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 927 934 927 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1011 1018 1011 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1287 1294 1287 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 153 157 <span type="species:ncbi:10090">Mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
ITK is expressed primarily in T cells, NK cells and mast cells [11-13]. In T cells, it is rapidly activated following TcR crosslinking in vitro [14,15]. Mice lacking ITK exhibit reduced proliferation and IL-2 production in vitro, and reduced T cell differentiation in vitro and in vivo, with TH2 cell differentiation preferentially affected [15-19]. The observed reduced proliferation of ITK null T cells in vitro is IL-2 dependent as it could be rescued by the addition of exogenous IL-2 [20]. However, these animals are not entirely immunocompromised, with residual responses against LCM, Vaccinia and VS viruses [21]. We have tested whether ITK null mice are susceptible to SEB induced IL-2 secretion. We show here that mice lacking ITK have much reduced IL-2 production and T cell expansion in response to SEB in vitro and in vivo. We also show that SEB induced the activation of the JNK MAPK pathway in responding T cells in vivo, and that ITK null T cells were defective in the activation of this pathway in vivo. However, toxicity analysis indicated that both WT and ITK null animals were similarly affected by SEB exposure. Our data suggest that ITK is required for full IL-2 secretion following SEB exposure, and that this may be due to the regulation of the JNK pathway by ITK in vivo. However, reducing T cell signals does not necessarily lead to better physiological responses to SEB exposure.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 112 120 112 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
ITK deficient T cells proliferate less efficiently than WT T cells in response to varying concentrations of SEB in vitro
###end title 13
###begin p 14
###xml 144 153 144 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 441 448 441 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 628 636 628 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 720 729 720 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1057 1059 1051 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 1174 1176 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1298 1303 1292 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a, b</xref>
###xml 1717 1719 1710 1712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 1855 1859 1848 1852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1d&#8211;f</xref>
###xml 2069 2077 2062 2070 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 1207 1211 <span type="species:ncbi:10090">mice</span>
###xml 1405 1409 <span type="species:ncbi:10090">mice</span>
###xml 1454 1458 <span type="species:ncbi:10090">mice</span>
It has previously been reported that T cells from mice lacking ITK exhibit much reduced proliferation in response to anti-CD3 or TcR antibodies in vitro [15,16,18]. By contrast, these T cells did not have any defects and actually had higher proliferative responses following anti-CD28/PMA stimulation [20]. These data do not provide clear answers as to whether ITK would present a good target for inhibition of SEB induced T cell activation in vivo, and in particular, in the cytokine response observed following SAG exposure. We therefore first tested whether ITK null T cells could respond to SEB stimulation by proliferation in vitro. Pooled splenocytes and lymph node cells from WT or ITK null animals were cultured in vitro in the presence of varying concentrations of SEB (5 mug/ml, 0.5 mug/ml, 0.05 mug/ml, 0.005 mug/ml, and 0.0005 mug/ml), and proliferation analyzed over a 5-day period. We found that WT cells responded normally by proliferating between days 2 and 3, with maximum proliferation observed at day 5 and the 5 mug/ml dose of SEB (Fig. 1a). Analysis of the dose response at 5 days indicated that the WT cells responded in a dose dependent fashion (Fig. 1b). By contrast, cells from ITK mice showed very little response, regardless of the dose of SEB used for stimulation (Fig. 1a, b). We next determined if the same results would be obtained in purified T cell populations from these mice. T cells were purified from WT and ITK null mice, and stimulated with varying dose of SEB, in the presence of APCs. Analysis of the data over the 5 days indicated that in the presence of the highest concentration of SEB tested (10 mug/ml), WT T cells responded more robustly than ITK null T cells (see Fig. 1c). Indeed, at all the doses tested, our analysis indicated that ITK null T cells responded less than WT T cells on day 3, 4 and 5 (Fig. 1d-f), while proliferation was equivalent when PMA and Ionomycin was used to bypass TcR signals (data not shown). These data indicate that ITK null T cells have significantly reduced proliferative responses to SEB in vitro.
###end p 14
###begin title 15
###xml 54 62 54 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
ITK null T cells secrete less IL-2 in response to SEB in vitro
###end title 15
###begin p 16
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 117 126 117 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 321 330 321 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 336 337 336 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a</xref>
###xml 536 539 534 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2bi</xref>
###xml 781 783 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b</xref>
###xml 946 948 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 949 951 946 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 952 954 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 955 957 952 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
Interleukin-2 is one of the cytokines induced by exposure to SEB [22]. ITK has been shown to regulate IL-2 secretion in vitro by T cells stimulated anti-CD3/TcR antibodies or in response to peptide antigen [15,18,23,24]. We therefore determined the levels of IL-2 in supernatants from cells similarly stimulated with SEB in vitro (Fig. 2). While WT T cells responded to SEB by secretion of IL-2 within 24 hrs. of stimulation in a dose dependent manner (see Fig. 2a for 5 mug/ml dose), starting at the 0.5 mug/ml SEB concentration (Fig. 2bi), ITK null T cells made very little IL-2, and the small amount of IL-2 that was made was only at the highest concentration of SEB tested (5 mug/ml). ITK null T cells consistently secreted less IL-2 over the 5-day period and dose range (Fig. 2b). These data indicate that as previously reported for TcR or antigenic stimulation, ITK regulates the production of IL-2 in vitro in response to SEB stimulation [15,18,23,24].
###end p 16
###begin title 17
###xml 27 28 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 31 33 28 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 92 99 89 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Reduced expansion of Vbeta8+CD4+ population in ITK null animals in response to SEB exposure in vivo
###end title 17
###begin p 18
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 193 200 193 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 632 634 626 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 983 985 968 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1080 1084 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a,b</xref>
###xml 1103 1104 1085 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1249 1250 1228 1229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1253 1254 1232 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1329 1333 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a,b</xref>
###xml 1488 1489 1464 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1553 1560 1529 1536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1462 1466 <span type="species:ncbi:10090">mice</span>
While these data indicate that ITK regulates T cell proliferation in response to SEB in vitro, it is possible that within the context of antigen presentation and optimal co-stimulatory signals in vivo, ITK null T cells may exhibit a better response. Exposure of animals to SEB results in an expansion of the SEB reactive T cell population with a peak of around 2 days post exposure [2,4]. In order to determine if the reduced proliferative responses seen with the ITK null T cells in vitro was also seen in vivo, we exposed WT and ITK null animals to SEB and determined the percentages of Vbeta8 and Vbeta6 positive cells in the CD4+ population by flow cytometry after 2, 4 and 5 days as a measure of T cell expansion. T cells bearing Vbeta8 TcR chains are responsive to SEB stimulation while those that bear Vbeta6 TcR chains are not, so we analyzed these two populations of T cells. As previously reported, in WT animals, we observed an approximately 4 fold expansion in Vbeta8 CD4+  T cells in spleen and lymph nodes following SEB exposure (as compared to exposure to PBS, fig 3a,b), while Vbeta6 CD4+ T cell populations were largely unchanged (data not shown). By contrast, there was statistically significantly less expansion of ITK null Vbeta8+CD4+ T cells following SEB exposure, although these cells still expanded (Fig. 3a,b) As previously reported, the percentages of T cells bearing Vbeta6 did not change over this period in either the WT or ITK null mice (data not shown and [4]). Thus the absence of ITK results in reduced T cell expansion in vivo in response to SEB. 
###end p 18
###begin title 19
###xml 37 45 37 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Defective SEB induced IL-2 secretion in vivo in ITK null mice
###end title 19
###begin p 20
###xml 44 53 44 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 102 111 102 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 218 225 218 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 381 390 381 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 440 448 440 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 517 518 517 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 554 563 554 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 646 654 646 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 701 709 701 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 754 762 754 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 856 863 856 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 929 936 929 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 415 419 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
T cells from ITK null mice proliferate less in vitro and in vivo, and secrete significantly less IL-2 in vitro in response to SEB. We therefore determined if they would also secrete less IL-2 following SEB stimulation in vivo. Groups of mice were exposed to SEB i.v. and at various time points their serum was taken and analyzed for IL-2 production. We found that in comparison to in vitro IL-2 production, when WT mice were exposed to SEB in vivo they produced IL-2 within 1 hr., which peaked at around 2 hrs. (Fig. 4). In addition, consistent with the in vitro stimulation, ITK deficient mice secrete significantly less IL-2 in response to SEB in vivo (Fig. 4). Based on these data we conclude that in vivo IL-2 production occurs earlier than observed in vitro, and that ITK null T cells continue to exhibit defects in IL-2 production in response to SEB in vivo, even in the presumed presence of adequate costimulatory signals in vivo.
###end p 20
###begin title 21
Defective phosphorylation of c-jun induced by SEB in ITK null T cells
###end title 21
###begin p 22
###xml 120 129 120 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 442 450 442 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 494 501 494 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 562 570 562 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 683 690 683 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 811 819 811 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1251 1253 1245 1247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1263 1264 1257 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1330 1332 1321 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1436 1450 1427 1441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a, b iii &amp; iv</xref>
###xml 1611 1613 1599 1601 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1680 1693 1668 1681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a, b, i &amp; ii</xref>
###xml 2147 2151 2135 2139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5a&#8211;b</xref>
###xml 858 862 <span type="species:ncbi:10090">mice</span>
The JNK MAPK pathway has been shown to be essential for IL-2 production upon stimulation of T cells by the TcR and CD28 in vitro [25-28]. This pathway leads to phosphorylation of c-jun and activation of an AP-1 transcription factor complex that is required for IL-2 transcription [28]. While activation of the JNK pathway leading to phosphorylation and activation of c-jun has been demonstrated in T cells following TcR and CD28 crosslinking in vitro, as well as by peptide antigen stimulation in vivo, it is not clear whether the SAG SEB activates this pathway in vivo [29,30]. We therefore tested whether SEB could induce phosphorylation of c-jun in WT T cells stimulated with SEB in vivo. To do this, we adapted a method initially used by Jenkins and colleagues to analyze phosphorylation of c-jun following in vivo exposure of antigen. In this protocol, mice were exposed to SEB, then cells from lymph nodes, spleen and blood rapidly isolated and fixed, and antibodies specific for phosphorylated c-jun used to analyze its phosphorylation. In addition, cells were stained with antibodies specific to Vbeta8 or Vbeta6 to detect SEB responsive and non-responsive T cells respectively. Flow cytometry was employed to detect phosphorylation of c-jun [30]. Figure 5 demonstrates that 1 hr. after intravenous exposure to SEB, Vbeta8+ SEB reactive T cells in spleen and lymph nodes contain higher levels of phosphorylated c-jun (cf. Figs. 5a, b iii & iv). Similar results were found in animals exposed to SEB i.p. (data not shown). By contrast, T cells non-reactive to SEB in the same animals, those bearing Vbeta6+ TcRs, did not have any increase in phosphorylated c-jun (cf. Figs. 5a, b, i & ii). This demonstrates that in the same animal, only those T cells that interact with and can be activated by SEB respond by phosphorylation of c-jun, while at the same time, those T cells that are not reactive are not activated, demonstrating specificity. Similarly, animals injected with PBS showed no such change in phosphorylated c-jun in either the SEB reactive or non-reactive T cell populations, indicating that this was an SEB mediated event (Fig. 5a-b). Other controls including secondary reagents alone demonstrate the specificity of antibody staining (data not shown).
###end p 22
###begin p 23
###xml 112 119 112 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 224 226 221 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 268 270 262 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 455 459 449 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6a&#8211;d</xref>
###xml 975 977 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 978 980 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1179 1180 1173 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1205 1206 1196 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1209 1211 1200 1202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1233 1234 1221 1222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1237 1239 1225 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1432 1433 1420 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 1505 1506 1490 1491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1509 1511 1494 1496 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 1273 1277 <span type="species:ncbi:10090">mice</span>
###xml 1540 1544 <span type="species:ncbi:10090">mice</span>
###xml 1562 1566 <span type="species:ncbi:10090">mice</span>
We next determined whether T cells lacking ITK could induce c-jun phosphorylation in response to SEB activation in vivo. ITK null mice were exposed to SEB as described above, and phosphorylation of c-jun determined in Vbeta8+ T cell population (SEB reactive) or Vbeta6+ T cell population (non-reactive) in the same animals. These experiments show that in the absence of ITK, SEB does not lead to phosphorylation of c-jun in either T cell population (Fig. 6a-d). Thus, the absence of ITK results in the lack of SEB phosphorylation of c-jun, which could affect the ability of these T cells to produce IL-2. To determine if this lack of c-jun phosphorylation in ITK null T cells in response to SEB reflected global nonresponsiveness in these cells, we determined whether these cells were indeed activated by SEB exposure. To do this, we measured increases in CD69 expression, a cell surface protein that is rapidly expressed by activated T cells in a Ras/MAPK dependent manner [31-33]. Similar experiments were performed as those examining c-jun phosphorylation, except that we used specific antibodies against CD69 to determine if the SEB reactive cells had been activated. Figure 7 demonstrates that Vbeta8+CD4+ T cells but not Vbeta6+CD4+ T cells from both WT and ITK null mice exhibited increases in CD69 expression 2 hours following SEB exposure, indicating that in both cases, the T cells were responding to SEB activation (Fig. 7). However, SEB induced CD69 expression on a higher percentage of Vbeta8+CD4+ SEB responding T cells in WT mice than in ITK null mice (73.5 +/- 12% in WT vs. 43.6 +/- 0.5% in ITK null). However, there was no difference in the MFI of CD69 expression WT responding T cells vs. ITK null responding T cells (362.5 _+/- 6.3 in WT vs. 375 +/- 11.3 in ITK null). In addition, there was no difference in the expression of CD25 on WT or ITK null T cells (data not shown). Thus the lack of SEB induced c-jun phosphorylation in ITK null T cells seems to reflect the specific role of ITK in regulating this event in response to SEB exposure in vivo.
###end p 23
###begin title 24
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Similar toxicity of SEB on WT and ITK null mice
###end title 24
###begin p 25
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 303 307 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
Exposure of mice to SEB and LPS results in toxicity culminating in death [1]. We therefore analyzed the effect of exposure to SEB/LPS on ITK null mice. However, in contrast to the results with IL-2 secretion and T cell expansion, both mice were affected similarly (Table 1). Thus the same proportion of mice became sick following exposure to SEB and LPS, suggesting that although the absence of ITK affects IL-2 secretion following SEB exposure, its absence does not affect the ability of SEB to induce sickness in these mice.
###end p 25
###begin title 26
Discussion
###end title 26
###begin p 27
###xml 157 158 157 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 161 163 161 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 609 613 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
###xml 1069 1073 <span type="species:ncbi:10090">mice</span>
It is well established that exposure to SEB results in large scale cytokine production, which in part is responsible for symptoms of exposure to this toxin [1,2,35]. T cells have been shown to be largely responsible for this excessive cytokine production [35,36]. Current suggestions for pharmacologically blocking the symptoms of SEB exposure include T cell signal transduction inhibitors such as CsA and Perfenidone, however, these agents have significant side effects [37,38]. Here we present a promising target for inhibition IL-2 production induced by SEB exposure, the tyrosine kinase ITK. We show that mice lacking ITK have significantly reduced T cell expansion and IL-2 secretion upon exposure to SEB in vivo. Furthermore, we show that the SEB induced signaling pathway leading to c-jun phosphorylation, an indication of JNK pathway activation, is significantly reduced in ITK null T cells, although these T cells could respond to SEB activation by upregulating CD69, and there was no difference in the overall toxicity of SEB/LPS in these mice compared to WT mice.
###end p 27
###begin p 28
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 297 306 297 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 438 447 438 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 495 504 495 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 542 551 542 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 578 585 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 683 692 683 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 851 858 851 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 995 1004 995 1004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 1055 1057 1055 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1125 1134 1125 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1135 1137 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1138 1140 1138 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1254 1261 1254 1261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 1010 1014 <span type="species:ncbi:10090">mice</span>
Previous work performed in vitro suggests that ITK is required for the anti-TcR/CD3 antibody mediated activation of the transcription factor NFAT, via regulation of calcium influx into TcR stimulated T cells [19,39]. ITK null T cells also exhibit reduced AP-1 DNA binding activity when stimulated in vitro with anti-CD3 antibodies [19]. It has also been shown that JNK activation lies in part downstream of ITK following TcR crosslinking in vitro [23]. However, these experiments were performed in vitro and it is not clear that effects seen in vitro would reflect what happens in vivo, since other cell-cell interactions may allow for activation of pathways that are not seen using in vitro activation with antibodies. Our data however, suggest that indeed, ITK lies downstream of the TcR and is required for IL-2 secretion and c-jun phosphorylation in vivo. Corroborating a role for c-jun activation in IL-2 production, mice carrying a dominant negative c-jun have much reduced IL-2 secretion in vitro [28] (mice lacking c-jun die during embryogenesis [40]). Similarly, JNK has been implicated in IL-2 secretion by T cells in vitro [25-27]. Our data lend support to this idea that the JNK-c-jun pathway is involved in the production of IL-2 by T cells in vivo.
###end p 28
###begin p 29
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
###xml 691 695 <span type="species:ncbi:10090">mice</span>
Curiously, the immunosuppresant CsA has been shown to inhibit the effects of SEB exposure in mice if delivered prior to SEB exposure [36], however it does not inhibit SEB induced effects in monkeys if delivered at the same time as SEB [38]. The effects of CsA on SEB induced symptoms has been suggested to be due to its effects on inhibiting IL-2 and other cytokine production due to inhibition of activation of the transcription factor NFAT [36,41], however, CsA also inhibits activation of the JNK pathway following TcR/CD3 and CD28 stimulation [29,30], and so CsA pretreatment may act to prevent early T cell activation of these pathways, thus blocking cytokine production and protecting mice from the effects of subsequent SEB exposure.
###end p 29
###begin p 30
###xml 100 102 100 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 551 552 548 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 555 557 552 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1088 1090 1085 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 712 716 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1014 1018 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
###xml 1173 1177 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:10090">mice</span>
Mice lacking ITK exhibit reduced T cell responses in vitro, but also have reduced percentages of CD4+ T cells (approximately 60-70% of WT, [16]). While this would be expected to reduced the overall T cell response in vivo to SEB exposure, if these cells were able to respond to SEB, we would expect an equivalent reduction in the amount of IL-2 secreted in vivo in response to SEB. We would also expect to see an equivalent reduction in proliferation in vitro. However, in vivo, we observed much reduced IL-2 secretion, and reduced expansion of Vbeta8+CD4+ T cells, although this was not as dramatic as the reduction in IL-2 secretion. Indeed, it has been observed that SEB induced T cell expansion in IL-2 null mice, indicating that IL-2 is not necessary for expansion of T cells in vivo following SEB exposure. However, even with the reduced T cell responses observed in ITK null mice, they still suffer from SEB/LPS induced toxicity similar to that seen in the WT mice. It should be noted however, that C57BL/6 mice are much less sensitive to SEB induce lethal shock than Balb/c mice [34]. Thus we observed very few deaths in our experiments, and ITK may protect Balb/c mice from actual death. We are currently crossing these mice onto the Balb/c background to determine if this is the case.
###end p 30
###begin title 31
Conclusion
###end title 31
###begin p 32
###xml 84 104 84 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo and in vitro</italic>
###xml 236 240 <span type="species:ncbi:10090">mice</span>
In conclusion, we have show that ITK is required for IL-2 production induced by SEB in vivo and in vitro. We have also shown that ITK may regulate signals leading IL-2 production in part by regulating phosphorylation of c-jun. However, mice lacking ITK exhibit similar responses to SEB toxicity. The data suggest that the inability of T cell lacking ITK to produce IL-2 cannot be overcome by SAG stimulation, and that perturbing T cell activation pathways leading to IL-2 production does not necessarily lead to improved responses to SEB toxicity.
###end p 32
###begin title 33
Methods
###end title 33
###begin title 34
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 34
###begin p 35
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 122 126 122 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 33 37 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
Wild type mice and ITK-deficient mice (C57BL/6 background, [16]) between 8 and 10 weeks were used in all experiments. RAG1-/- mice were a kind gift of Dr. Eric Harvill (Penn State University) and were similarly used between 6-10 weeks of age. The Institutional Animal Care and Use Committee of The Pennsylvania State University approved all experiments.
###end p 35
###begin title 36
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
In vivo expansion assays
###end title 36
###begin p 37
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
WT and ITK deficient mice were injected intraperitoneally (i.p.) with 50 mug SEB in PBS (Sigma-Aldrich, St. Louis, MO) and after 2 days, were sacrificed and splenocytes stained with antibodies specific for Vbeta8 (SEB reactive T cells) or Vbeta6 (non-reactive T cells) and CD4 directly conjugated to FITC and PE respectively (BDPharmingen, San Diego, CA). Alternatively, mice were injected i.p. with 50 mug SEB and eye-bled every 2 days for 5 days. Following lysis of red blood cells, the remaining cells were stained as described above for the splenocytes. Lymphocytes were identified by flow cytometry by their forward and side scatter characteristics.
###end p 37
###begin title 38
Intracellular staining
###end title 38
###begin p 39
###xml 518 520 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 791 792 784 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 870 872 863 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 849 855 <span type="species:ncbi:9986">rabbit</span>
###xml 861 866 <span type="species:ncbi:10090">mouse</span>
We used a protocol reported by Zell et al to determine the phosphorylation status of c-jun, as a measure of activation of the JNK-c-jun pathway in SEB responding T cells. WT and ITK deficient mice were injected i.p. or intravenously (i.v.) with 50 mug SEB and allowed to survive for an 1 hr. Similar results were found with both routes of administration. Animals were sacrificed and spleens, lymph nodes, and blood rapidly isolated, and dounced in 2% paraformaldehyde to rapidly fix the cells as previously described [30]. Cells were stained with antibodies to Vbeta8 or Vbeta6 directly conjugated to PE (BDPharmingen, San Diego, CA), then permeabilized with saponin. Cells were then stained for intracellular phosphorylated-c-jun with a monoclonal antibody against phosphorylated c-jun (IgG1, Cell Signaling, Beverly, MA), followed by biotinylated rabbit anti-mouse IgG1 and streptavidin conjugated to FITC. Controls included secondary reagents alone. Upregulation of CD69 by SEB in vivo was performed using similar approaches, except that T cells were not fixed or permeabilized prior to staining with PE-conjugated anti-CD69 monoclonal antibody (BDPharmingen, San Diego, CA). This was followed by analysis by flow cytometry, with post analysis performed using the WinMDI program 2.8 (The Scripps Research Institute, La Jolla, CA).
###end p 39
###begin title 40
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro proliferation
###end title 40
###begin p 41
###xml 354 356 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 659 661 647 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
Lymph nodes and spleens were isolated from WT and ITK deficient mice and pooled. Red blood cells were removed using ACK lysis buffer, and cells resuspended in complete RPMI. Cells were then left unstimulated or stimulated with varying concentrations of SEB (5 mug/ml, 0.5 mug/ml, 0.05 mug/ml, 0.005 mug/ml, and 0.0005 mug/ml) at a concentration of 2 x 106 cells/ml. These cells were incubated at 37degreesC for 5 days and pulsed once a day for 5 days with 0.5 muCi tritiated thymidine per well for 12 hrs. before harvest. T cells were purified from WT and ITK null mice using MiniMACS separation columns (Miltenyi Biotec Inc, Auburn, CA), and plated at 2 x 106 cells/ml and stimulated as above, in the presence of splenocytes from RAG null mice pre-treated with mitomycin C. All experiments were done in triplicate.
###end p 41
###begin title 42
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro cytokine analysis
###end title 42
###begin p 43
###xml 219 228 214 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Pooled lymphocytes and splenocytes from WT and ITK deficient mice were incubated with varying concentrations of SEB (5 mug/ml, 0.5 mug/ml, 0.05 mug/ml, 0.005 mug/ml, and 0.0005 mug/ml) for 5 days as described above for in vitro proliferation. Supernatants were sampled once a day over this period and analyzed for IL-2 using ELISAs according to the manufacturer's recommendations (BDPharmingen, San Diego, CA).
###end p 43
###begin title 44
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
In vivo cytokine analysis
###end title 44
###begin p 45
###xml 21 25 <span type="species:ncbi:10090">mice</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
WT and ITK deficient mice were injected with 50 mug SEB i.v., and serum isolated from cardiac blood from mice 1, 2, 4, 8, 12, and 24 hrs. post SEB exposure and used to perform an ELISA to determine IL-2 levels. PBS injected mice served as controls, and there was no change in IL-2 secretion in these animals.
###end p 45
###begin title 46
Statistics
###end title 46
###begin p 47
Values were compared using student's t test and considered significant if p < 0.05.
###end p 47
###begin title 48
List of abbreviations used
###end title 48
###begin p 49
ITK Interleukin-2 inducible T cell Kinase
###end p 49
###begin p 50
IL-2 Interleukin-2
###end p 50
###begin p 51
SEB Staphylococcal Enterotoxin B
###end p 51
###begin p 52
SAG Superantigen
###end p 52
###begin p 53
Th1 T-helper 1 cells
###end p 53
###begin p 54
Th2 T-helper 2 cells
###end p 54
###begin p 55
Syk Spleen tyrosine kinase
###end p 55
###begin p 56
Zap-70 Zeta chain Associated protein-70
###end p 56
###begin p 57
Lck Lstra cell kinase
###end p 57
###begin p 58
MAPK Mitogen Activated Protein Kinase
###end p 58
###begin p 59
ERK Extracellular signal Regulated Kinase
###end p 59
###begin p 60
JNK c-jun N-terminal kinase
###end p 60
###begin p 61
NK Natural Killer cells
###end p 61
###begin p 62
LCM Lymphocytic Choriomeningitis
###end p 62
###begin p 63
VS Vesicular Stomatitis
###end p 63
###begin p 64
PMA Phorbol Myristic Acid
###end p 64
###begin p 65
PBS Phosphate Buffered Saline
###end p 65
###begin p 66
NFAT Nuclear Factor of Activated T cells
###end p 66
###begin p 67
AP-1 Activator protein 1
###end p 67
###begin p 68
CsA Cyclosporin A
###end p 68
###begin title 69
Authors' contributions
###end title 69
###begin p 70
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 128 129 128 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 137 138 137 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
AA designed the experiments. MJR and JH performed experiments leading to figure 1. MJR performed experiments leading to figures 2, 3, 4, 5, 6, 7. AA and AJH provided financial support and supervision. MJR, AJH and AA wrote the manuscript. All authors read and approved the final manuscript.
###end p 70
###begin title 71
Acknowledgements
###end title 71
###begin p 72
###xml 400 404 <span type="species:ncbi:10090">mice</span>
We thank members of the August lab and the Center for Molecular Immunology & Infectious Disease at Penn State for helpful comments and suggestions. We also thank Elaine Kunze and Susan Magargee in the Center for Quantitative Cell Analysis at Penn State for excellent technical help. We also thank Dr. Dan Littman (New York University Medical School, NY, NY) for kindly providing us with the ITK null mice.
###end p 72
###begin p 73
This work was supported in part by a Johnson & Johnson Focused Giving Grant (to A.A.), the American Heart Association (0330036N), and Public Health Service Grants AI-51626 (to A.A.) and AI-46261 (to A.J.H.). MJR is a Ford Foundation Scholar.
###end p 73
###begin article-title 74
###xml 13 34 <span type="species:ncbi:1280">Staphylococcus aureus</span>
Exotoxins of Staphylococcus aureus.
###end article-title 74
###begin article-title 75
###xml 42 47 <span type="species:ncbi:9606">human</span>
Superantigens and their potential role in human disease.
###end article-title 75
###begin article-title 76
###xml 42 46 <span type="species:ncbi:10090">mice</span>
T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor.
###end article-title 76
###begin article-title 77
Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo.
###end article-title 77
###begin article-title 78
###xml 82 86 <span type="species:ncbi:10090">mice</span>
Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice.
###end article-title 78
###begin article-title 79
In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B.
###end article-title 79
###begin article-title 80
Beyond calcium: new signaling pathways for Tec family kinases.
###end article-title 80
###begin article-title 81
The Tec Family of tyrosine kinases in T cells, amplifiers of T cell receptor signals.
###end article-title 81
###begin article-title 82
New insights into the regulation and functions of Tec family tyrosine kinases in the immune system.
###end article-title 82
###begin article-title 83
T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse. Erratum in: J Allergy Clin Immunol 2002 Jul;110(1):25.
###end article-title 83
###begin article-title 84
The EMT/ITK/TSK (EMT) tyrosine kinase is activated during TcR signaling: LCK is required for optimal activation of EMT.
###end article-title 84
###begin article-title 85
###xml 30 36 <span type="species:ncbi:10090">murine</span>
Developmental regulation of a murine T-cell specific tyrosine kinase gene, Tsk.
###end article-title 85
###begin article-title 86
Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells.
###end article-title 86
###begin article-title 87
###xml 130 135 <span type="species:ncbi:9606">human</span>
CD28 is associated with and induces the immediate tyrosine phosphorylation and activation of the Tec family kinase ITK/EMT in the human Jurkat leukemic T-cell line.
###end article-title 87
###begin article-title 88
T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells.
###end article-title 88
###begin article-title 89
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk.
###end article-title 89
###begin article-title 90
###xml 60 64 <span type="species:ncbi:10090">Mice</span>
Attenuation of Immunological Symptoms of Allergic Asthma in Mice Lacking the Tyrosine Kinase ITK.
###end article-title 90
###begin article-title 91
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity.
###end article-title 91
###begin article-title 92
Mutation of Tec family kinases alters T helper cell differentiation.
###end article-title 92
###begin article-title 93
Itk negatively regulates induction of T cell proliferation by CD28 costimulation.
###end article-title 93
###begin article-title 94
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Antiviral immune responses in Itk-deficient mice
###end article-title 94
###begin article-title 95
###xml 232 238 <span type="species:ncbi:10090">murine</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
Relative strength of the mitogenic and interleukin-2-production-inducing activities of staphylococcal exotoxins presumed to be causative exotoxins of toxic shock syndrome: toxic shock syndrome toxin-1 and enterotoxins A, B and C to murine and human T cells.
###end article-title 95
###begin article-title 96
Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase.
###end article-title 96
###begin article-title 97
Itk phosphorylation sites are required for functional activity in primary T cells.
###end article-title 97
###begin article-title 98
JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development.
###end article-title 98
###begin article-title 99
Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes.
###end article-title 99
###begin article-title 100
c-Jun NH2-terminal Kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation.
###end article-title 100
###begin article-title 101
A dominant-negative mutant of c-Jun inhibits cell cycle progression during the transition of CD4(-)CD8(-) to CD4(+)CD8(+) thymocytes.
###end article-title 101
###begin article-title 102
JNK is involved in signal integration during costimulation of T lymphocytes.
###end article-title 102
###begin article-title 103
Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo.
###end article-title 103
###begin article-title 104
Differential T-cell antigen receptor signaling mediated by the Src family kinases Lck and Fyn.
###end article-title 104
###begin article-title 105
Raf-1 provides a dominant but not exclusive signal for the induction of CD69 expression on T cells.
###end article-title 105
###begin article-title 106
Involvement of p21ras activation in T cell CD69 expression.
###end article-title 106
###begin article-title 107
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Correlation of temperature and toxicity in murine studies of staphylococcal enterotoxins and toxic shock syndrome toxin 1.
###end article-title 107
###begin article-title 108
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Staphylococcal enterotoxin-B-induced lethal shock in mice is T-cell-dependent, but disease susceptibility is defined by the non-T-cell compartment.
###end article-title 108
###begin article-title 109
###xml 48 52 <span type="species:ncbi:10090">mice</span>
The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells.
###end article-title 109
###begin article-title 110
Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B.
###end article-title 110
###begin article-title 111
###xml 87 101 <span type="species:ncbi:9544">rhesus monkeys</span>
###xml 103 117 <span type="species:ncbi:9544">Macaca mulatta</span>
Cellular and cytokine responses in the circulation and tissue reactions in the lung of rhesus monkeys (Macaca mulatta) pretreated with cyclosporin A and challenged with staphylococcal enterotoxin B.
###end article-title 111
###begin article-title 112
Impaired NFATc Translocation and Failure of Th2 Development in Itk Deficient CD4 T Cells.
###end article-title 112
###begin article-title 113
A null mutation at the c-jun locus causes embryonic lethality and retarded cell growth in culture.
###end article-title 113
###begin article-title 114
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.
###end article-title 114
###begin article-title 115
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice.
###end article-title 115
###begin title 116
Figures and Tables
###end title 116
###begin p 117
###xml 28 37 28 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ITK regulates proliferation <italic>in vitro </italic>in response to SEB</bold>
###xml 320 323 320 323 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a) </bold>
###xml 337 340 336 339 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b) </bold>
###xml 556 559 554 557 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c) </bold>
###xml 641 644 637 640 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d) </bold>
###xml 652 655 648 651 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e) </bold>
###xml 665 668 661 664 <bold xmlns:xlink="http://www.w3.org/1999/xlink">f) </bold>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
ITK regulates proliferation in vitro in response to SEB. Splenocytes and lymph node cells from WT (filled circles) and ITK deficient (open circles) mice were stimulated in vitro with the indicated concentrations of SEB, and proliferative response determined. Time course of proliferation over the indicated doses of SEB a) 5 mug/ml SEB, b) dose curve of 0.0005, 0.005, 0.05, 0.5, & 5 mug/ml SEB analyzed at 5 days post stimulation. Purified WT (filled circles) and ITK deficient (open circles) T cells were stimulated in vitro over the indicated time with c) 10 mug/ml SEB, or a dose curve of 0.01, 0.1, 1, and 10 mug/ml SEB and analyzed at d) 3 days, e) 4 days or f) 5 days post stimulation. * indicates statistically significant difference with a p < 0.05.
###end p 117
###begin p 118
###xml 29 38 29 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 0 56 0 56 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ITK regulates IL-2 secretion <italic>in vitro </italic>in response to SEB</bold>
###xml 272 275 272 275 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a) </bold>
###xml 327 330 326 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b) </bold>
###xml 381 385 380 384 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i) </bold>
###xml 392 397 391 396 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(ii) </bold>
###xml 404 410 403 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iii) </bold>
###xml 417 422 416 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iv) </bold>
###xml 432 436 431 435 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(v) </bold>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
ITK regulates IL-2 secretion in vitro in response to SEB. Splenocytes and lymph node cells from WT (filled circles) or ITK deficient (open circles) mice were stimulated in vitro with the indicated concentrations of SEB and IL-2 levels secreted in supernatants determined. a) Time course of IL-2 secretion at 5 mug/ml SEB dose. b) IL-2 secretion over the indicated times and doses. (i) Day 1; (ii) Day 2; (iii) Day 3; (iv) Day 4 and (v) Day 5. * indicates statistically significant difference with a p < 0.05.
###end p 118
###begin p 119
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 60 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Reduced T cell expansion in response to SEB exposure <italic>in vivo</italic></bold>
###xml 62 65 62 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a) </bold>
###xml 281 282 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 285 287 281 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 315 316 308 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 319 321 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 364 367 357 360 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b) </bold>
###xml 429 430 419 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 433 435 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Reduced T cell expansion in response to SEB exposure in vivo. a) WT (filled circles) or ITK deficient mice (open circles) were injected with 50 mug SEB i.p. and peripheral blood lymphocytes analyzed after 2, 4 and 5 days as in the materials and methods for the percentage of Vbeta8+CD4+ T cells as indicated (Vbeta6+CD4+ T cells showed no change, data not shown). b) The same data plotted as fold increase in percentage of Vbeta8+CD4+ T cells in peripheral blood. * indicates a statistically significant difference with a p < 0.05.
###end p 119
###begin p 120
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ITK null mice secrete less IL-2 in response to SEB exposure <italic>in vivo</italic></bold>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
ITK null mice secrete less IL-2 in response to SEB exposure in vivo. WT (filled circles) and ITK deficient (open circles) mice were injected i.v. with 50 mug SEB and blood sampled after 1, 2, 4, 8, 12 and 24 hrs. post injection. IL-2 in serum was determined by ELISA.
###end p 120
###begin p 121
###xml 77 84 77 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 84 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SEB induces activation of the JNK pathway specifically in responding T cells <italic>in vivo</italic></bold>
###xml 268 270 264 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 280 282 273 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 302 305 295 298 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a) </bold>
###xml 305 313 298 306 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Spleen: </bold>
###xml 313 317 306 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(i) </bold>
###xml 351 353 341 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 385 390 375 380 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(ii) </bold>
###xml 424 426 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 458 464 445 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iii) </bold>
###xml 498 500 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 548 553 532 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iv) </bold>
###xml 584 586 565 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 635 638 616 619 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b) </bold>
###xml 638 654 619 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lymph Node: (i) </bold>
###xml 688 690 666 668 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 722 727 700 705 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(ii) </bold>
###xml 761 763 736 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 795 801 770 776 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iii) </bold>
###xml 835 837 807 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 885 890 857 862 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(iv) </bold>
###xml 921 923 890 892 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
###xml 716 720 <span type="species:ncbi:10090">mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 958 962 <span type="species:ncbi:10090">mice</span>
SEB induces activation of the JNK pathway specifically in responding T cells in vivo. WT mice were injected with 50 mug SEB or PBS i.v. and sacrificed after 1 hr. Spleen and lymph nodes were harvested and analyzed for the presence of phosphorylated c-jun in the Vbeta8+ and Vbeta6+ T cell populations. a) Spleen: (i) phosphorylation of c-jun in Vbeta6+ T cells from PBS injected mice. (ii) phosphorylation of c-jun in Vbeta6+ T cells from SEB injected mice. (iii) phosphorylation of c-jun in Vbeta8+ T cells from the same PBS injected mice in (i). (iv) phosphorylation c-jun in Vbeta8+ T cells from the same SEB injected mice in (ii). b) Lymph Node: (i) phosphorylation of c-jun in Vbeta6+ T cells from PBS injected mice. (ii) phosphorylation of c-jun in Vbeta6+ T cells from SEB injected mice. (iii) phosphorylation of c-jun in Vbeta8+ T cells from the same PBS injected mice in (i). (iv) phosphorylation c-jun in Vbeta8+ T cells from the same SEB injected mice in (ii). Arrow points to the population of cells responding to SEB stimulation by activation of the JNK pathway by inducing c-jun phosphorylation.
###end p 121
###begin p 122
###xml 90 97 90 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 97 0 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ITK is required for SEB mediated induction of c-jun phosphorylation in responding T cells <italic>in vivo</italic></bold>
###xml 302 304 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 314 316 307 309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 345 347 335 337 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 378 380 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 411 413 395 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 450 452 431 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
ITK is required for SEB mediated induction of c-jun phosphorylation in responding T cells in vivo. WT (top panels) or ITK null (bottom panels) mice were injected with 50 mug SEB or PBS i.v. and sacrificed after 1 hr. Splenocytes were then analyzed for the presence of phosphorylated c-jun in the Vbeta8+ and Vbeta6+ T cell populations. a) Vbeta6+ T cells from WT mice; b) Vbeta8+ T cells from WT mice; c) Vbeta6+ T cells from ITK null mice; d) Vbeta8+ T cells from ITK null mice.
###end p 122
###begin p 123
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 0 86 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ITK is not necessary for SEB induced upregulation of CD69 inresponding T cells <italic>in vivo</italic></bold>
###xml 276 278 272 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 288 290 281 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 319 321 309 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 352 354 339 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 385 387 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 424 426 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 370 374 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 448 452 <span type="species:ncbi:10090">mice</span>
ITK is not necessary for SEB induced upregulation of CD69 inresponding T cells in vivo. WT (top panels) or ITK null (bottom panels) mice were injected with 50 mug SEB or PBS i.v. and sacrificed after 2 hrs. Splenocytes were then analyzed for the presence of CD69 on the Vbeta8+ and Vbeta6+ T cell populations. a) Vbeta6+ T cells from WT mice; b) Vbeta8+ T cells from WT mice; c) Vbeta6+ T cells from ITK null mice; d) Vbeta8+ T cells from ITK null mice.
###end p 123
###begin p 124
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 62 66 <span type="species:ncbi:10090">Mice</span>
###xml 204 208 <span type="species:ncbi:10090">mice</span>
###xml 323 327 <span type="species:ncbi:10090">Mice</span>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
###xml 472 477 <span type="species:ncbi:10090">mouse</span>
###xml 521 526 <span type="species:ncbi:10090">mouse</span>
Effect of SEB on health and survival of WT and ITK null mice. Mice (WT or ITK null) were injected with the indicated amount of LPS, followed 4 hours later by 50 mug SEB, both delivered Ip. Alternatively, mice were injected with 20 mg. D-Gal and 50 mug SEB at the same time. All injections were delivered intraperitoneally. Mice were then monitored for the presence of ruffled fur, mucous in feces and lethargy. *mice had ruffled fur, mucous in feces and were lethargic. **mouse died over the course of the experiment. ***mouse had to be euthanized due to severity of sickness.
###end p 124

